🦊/Investors

DAYLI Partners

Venture capital

Seoul · Seed–Late Stage

Find your way into DAYLI Partners

Fox Verdict
Sign up to see your fit

Investment thesis

DAYLI Partners positions itself as a specialized investment group focused on the bio and healthcare industries as well as finance and corporate governance. Leveraging differentiated expertise and strong execution capabilities, the firm seeks to lead industry evolution and innovation through its investments, with the goal of creating sustainable performance and returns.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Late Stage
HQ
Seoul, KR
Instruments
Equity
Founded
2018
AUM
$315M
Tracked investments
116
IPOs
2

What they invest in

from 9 of 116 portfolio companies

Healthtech ×6Biotech ×5Medical Devices ×4AI & Machine Learning ×2Digital Health ×2Advanced Manufacturing ×1Deep Tech ×1Hardware ×1

HQs:South Korea×4Indonesia×1

Investments · 116 tracked

founders shown can be your intro path
Trinity Biotechtrinitybiotech.comNASDAQ: TRIB

Trinity Biotech develops and manufactures diagnostic products for the medical diagnostics market, selling directly in the United States and through international distributors and strategic partners in over 100 countries.

BiotechHealthtechMedical Devices

Alodokteralodokter.comin𝕏

Alodokter runs an Indonesian health platform that combines medical reference articles with direct chat access to licensed doctors.

Healthtech

Suci Arumsari(Founder)inNathanael Faibisin

Co-investors500 GlobalGolden Gate VenturesWessel ManagementMDI VenturesSamsung Ventures

Arum Therapeuticsarumtherapeutics.com

Arum Therapeutics is a drug development company focused on identifying and targeting novel biological targets and signaling pathways to create new therapeutics.

Biotech

Mark Taegon Baik(Founder)in

Co-investorsAju IB Invesment Corporation

Carus Biocarusbio.com

CARUS Bio develops gene delivery systems and cell-derived biologics for therapeutic applications.

BiotechDeep TechHealthtechMedical DevicesSeoul, KR

신규 배

CMES Roboticscmesrobotics.ai

CMES Robotics builds AI-powered robotics systems that combine 3D vision and a proprietary AI core to inspect products, recognize objects, plan robot paths, and perform automated handling and manufacturing tasks.

Advanced ManufacturingAI & Machine LearningRobotics

Co-investorsAtinum Investment Co. Ltd.Kiwoom Investment

D&D Pharmatechddpharmatech.cominJun 2025

DD Pharmatech develops therapeutics for metabolic disorders, with a focus on oral and long-acting GLP-1 receptor agonist formulations.

Biotech

Seulki Lee(Executive Officer, Director)inSunghoon Hong(Executive Officer, Director)Sungmook Lim(Executive Officer, Director)

BoardDaehyun Shin(Director)Seungwon Lim(Director)Seol-Heui Han(Director)

Co-investorsKiwoom InvestmentLB InvestmentOctave Ventures Llc

Hyperfine Researchhyperfinemri.comin𝕏

Hyperfine develops the Swoop portable, point-of-care MRI system for brain imaging without ionizing radiation, used in clinical and research settings for infants, children, and adults.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Jonathan Rothberg(Founder)in

Co-investorsGV (Google Ventures)

IDienceidience.com

Idience is a biopharmaceutical company focused on developing and commercializing new medicines.

BiotechDigital HealthHealthtech

Won Sik Lee(Chief Executive Officer)inKyoung Soo Ha(Chief Medical Officer)Eun Kyung Kang(Chief Regulatory and Quality Officer)

Co-investorsKiwoom Investment

SkinGrabskingrab.co.kr

SKINGRAB is a South Korean manufacturer of energy-based aesthetic medical devices, including its FINIFF system, aimed at skincare professionals and patients.

HardwareHealthtechMedical Devices

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

3D MedivisionAldebaAM ScienceAngel RoboticsAntrogenAppCloneAston ScienceATsenseAutotech BioAvex Medical SystemsAyen TherapeuticsBaxel BioBayCensCellBeamworksBio OrchestraBreeze BioCareNationCaskure TherapeuticsCele MediCellidCelloramChamyakCurioxx BiosystemsCWEEEDCytotoxicsD&N BiotherapeuticsDeepCardioDoctor DiaryDoctor NowDreamtechElgen TherapeuticsElysigenEncloniEnliseENSOL BioscienceExosome PlusFirst BiotherapeuticFNCT BiotechGalaxicsGencel MedGenomictreeGI CellGI InnovationGT2 BioGT2iHighSense BioHueinnoHuons MeditechIlimis TherapeuticsIntucellJCIS MedicalJD BioscienceKanap TherapeuticsKCSBKey Prime ResearchLasemiaLigachem BioscienceLink SolutechLive Cell InstrumentsM Terra PharmaMarun TomorrowMaster MeditechMedifabMediOgenMedipixelMeditrixMicrodigitalMXT BiotechNeuroExtiNextGen BioscienceNoeulNovelty MobilityNuvi LabOn Us Link ItOnnuri StoreOpticoOrum TherapeuticsPanthologosPantomicsPharmCADPhASTPrecision BioPrimorise TherapeuticsProtium ScienceQuraumRanelaghRegen InnopharmRevosketchRibo TechRockit HealthcareSCM BioscienceSeedmogenSL TherapeuticsSNBIASNBioscienceSpace FSugen TechT&R BiofabTC NovabioTENESTherapexTomocubeUbix TherapeuticsUtilexWSGY BiologicsZenoplan

Exits · 2

2 IPOs · showing 1

Trinity BiotechNASDAQ: TRIB

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has DAYLI Partners made?
DAYLI Partners has 116 tracked investments, 2 of which have exited, including 1 dated in the last 24 months.
What stage does DAYLI Partners invest at?
DAYLI Partners invests at the Seed, Series A, Series B, Series C, Late Stage stages.
What sectors does DAYLI Partners focus on?
DAYLI Partners focuses on Biotech, Digital Health, Fintech, Healthtech, Medical Devices.
Where is DAYLI Partners located?
DAYLI Partners is headquartered in Seoul, KR.
Who does DAYLI Partners co-invest with?
DAYLI Partners most often shares deals with Kiwoom Investment, Atinum Investment Co. Ltd., LB Investment, among 6 tracked co-investors.

Images

DAYLI Partners photo

Similar investors

Featured in lists